Cibus, Inc. Submits SEC Filing Form 144 – What You Need to Know
In a recent SEC filing, Cibus, Inc. (CIK: 0001705843) submitted a Form 144 indicating an intention to sell restricted stock. This filing is significant as it provides transparency to investors about potential sales of restricted securities by company affiliates. Form 144 is typically filed by company insiders or affiliates looking to sell shares, and serves as a notice of their intent to do so.
Cibus, Inc. is a biotechnology company focused on developing sustainable and innovative solutions for the agriculture industry. Their proprietary technology allows for precise gene editing in plants, aiming to enhance crop traits and improve overall agricultural productivity. Investors and industry stakeholders will be keeping a close eye on any developments following this Form 144 filing by Cibus, Inc.
For more information on Cibus, Inc. and their cutting-edge biotechnology solutions, you can visit their official website at https://www.cibus.com. Stay tuned for any updates or announcements from the company following this recent SEC filing.
Read More:
Cibus, Inc. Submits SEC Filing Form 144 – Find Out More About the Company and Its Latest Update
